The AI Platform for equity research
Deploy Agentic AI today to track your coverage, offload manual review & surface signals faster.
Bridge the gap from hypothesis to conviction
Evaluating Piramal's shift from generics to high-value CDMO operations
Tracking molecule progress across peptides, ADCs, and injectables
Reviewing management cues on long-term partnerships
Conviction: Zero OAI status and USFDA approvals confirm late-phase scalability
Accelerate your research with instant, accurate and source-linked insights
Your AI Partner for Faster, Smarter Company Research
24/7 Research Analyst
Hours of research in seconds. Ask about any company metric, trend, or comparison with full citations.
Key Metrics, Zero Effort
Auto-generated financial profiles with every metric that matters, always current and accurate.
Track Markets
Track filings and news automatically. Get instant alerts with AI-summarized insights.
Automated Benchmarking
Compare companies across revenue, growth, and margins, no spreadsheets, no manual work
Start your research here
Breakdown MAX Healthcare FY25 net revenue by speciality in the table
For FY25, Max Healthcare Institute Ltd.'s net revenue breakdown by speciality is as follows:
Speciality
Oncology
Cardiac Sciences
Orthopaedics
Renal Sciences
Neurosciences
Internal Medicine
OBGY and Paediatrics
Gastroenterology
MAS and General Surgeries
Others
Pulmonology
Liver and Biliary Sciences
Total
Net Revenue (Rs Cr)
2,236.03
927.37
901.37
805.03
805.03
632.69
485.35
450.68
433.35
381.35
312.01
294.68
8,667.00
Contribution to Company's Revenue (%)
25.80% [1]
10.70% [1]
10.40% [1]
9.30% [2]
9.30% [1]
7.30% [1]
5.60% [2]
5.00% [2]
5.20% [2]
4.40% [2]
3.60% [2]
3.40% [2]
99.90%
DPIIT Certified by Government of India
Officially recognized by the Department for Promotion of Industry and Internal Trade
Unlock financial AI for your firm
